Seres Therapeutics's total assets for Q3 2024 were $178.74M, a decrease of -44.44% from the previous quarter. MCRB total liabilities were $154.82M for the fiscal quarter, a -62.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.